About the manufacturer

Biosensors International develops, manufactures and markets innovative medical devices for interventional cardiology and critical care procedures. With the increasing use of the BioMatrix™ family of drug-eluting stents, we are rapidly emerging as a leader in the global coronary stent market. The forthcoming launch of the Axxess™ self-expanding bifurcation drug-eluting stent and the development of the BioFreedom™ drug-coated stent will further reinforce our market position.

Phone: +41 21 804 80 00
Fax: +41 21 804 80 02
 

Page 1 of 1
Show results per page
Sort By:  A-Z / Rating / Date
Biomatrix-Flex-Stent-thumb.jpg

No Editor Review

No Ratings

BioMatrix Flex drug-eluting stent

The BioMatrix Flex™ stent system offers the unique combination of Biolimus A9™ (BA9™), an anti-restenotic drug developed and patented by Biosensors specifically for use with drug-eluting stents, combined with a biodegradable poly-lactic acid (PLA) polymer abluminally coated...

read full description
Share |

Latest News

Posted on : 17 May 2012
Return to impact sports such as jogging, soccer or martial arts is a goal for some patients after total hip arthroplasty... Read more
Posted on : 16 May 2012
The Ellipse ICD has recently received approval from the U.S. Food and Drug Administration (FDA)... Read more
Posted on : 14 May 2012
Researchers from the Hacettepe University, Ankara have demonstrated that using wii-sports after anterior cruciate ligament reconstruction is as good as conventional rehabilitation...  Read more
Posted on : 11 May 2012
Adding to the debate about bearing surfaces, a team from St Michael?s Hospital in Toronto studied 102 hip replacements in 91 patients... Read more
Posted on : 05 May 2012
The BMJ continues to demonstrate its interest in metal on metal hip replacements by publishing a study from Costa et al of Warwick University (1). 126 patients thought suitable for hip resurfacing... Read more